» Articles » PMID: 22353999

Quantitative Modeling of Chronic Myeloid Leukemia: Insights from Radiobiology

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2012 Feb 23
PMID 22353999
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Mathematical models of chronic myeloid leukemia (CML) cell population dynamics are being developed to improve CML understanding and treatment. We review such models in light of relevant findings from radiobiology, emphasizing 3 points. First, the CML models almost all assert that the latency time, from CML initiation to diagnosis, is at most ∼10 years. Meanwhile, current radiobiologic estimates, based on Japanese atomic bomb survivor data, indicate a substantially higher maximum, suggesting longer-term relapses and extra resistance mutations. Second, different CML models assume different numbers, between 400 and 10(6), of normal HSCs. Radiobiologic estimates favor values>10(6) for the number of normal cells (often assumed to be the HSCs) that are at risk for a CML-initiating BCR-ABL translocation. Moreover, there is some evidence for an HSC dead-band hypothesis, consistent with HSC numbers being very different across different healthy adults. Third, radiobiologists have found that sporadic (background, age-driven) chromosome translocation incidence increases with age during adulthood. BCR-ABL translocation incidence increasing with age would provide a hitherto underanalyzed contribution to observed background adult-onset CML incidence acceleration with age, and would cast some doubt on stage-number inferences from multistage carcinogenesis models in general.

Citing Articles

Stem cell graft dose and composition could impact on the expansion of donor-derived clones after allogeneic hematopoietic stem cell transplantation - a virtual clinical trial.

Stiehl T Front Immunol. 2024; 15:1321336.

PMID: 39737169 PMC: 11682905. DOI: 10.3389/fimmu.2024.1321336.


Modelling post-chemotherapy stem cell dynamics in the bone marrow niche of AML patients.

Zhu C, Stiehl T Sci Rep. 2024; 14(1):25060.

PMID: 39443599 PMC: 11500015. DOI: 10.1038/s41598-024-75429-7.


Archived Cytogenetic Cell Pellets Used to Detect a BCR::ABL1 Driver Mutation Eight Years before Disease Presentation.

Sasi R, Spruill M, Perrotta P Case Rep Hematol. 2024; 2024:2127657.

PMID: 38550770 PMC: 10977336. DOI: 10.1155/2024/2127657.


The structure of the hematopoietic system can explain chronic myeloid leukemia progression.

Perez-Jimenez M, Derenyi I, Szollosi G Sci Rep. 2023; 13(1):5411.

PMID: 37012292 PMC: 10070397. DOI: 10.1038/s41598-023-32400-2.


Life histories of myeloproliferative neoplasms inferred from phylogenies.

Williams N, Lee J, Mitchell E, Moore L, Baxter E, Hewinson J Nature. 2022; 602(7895):162-168.

PMID: 35058638 DOI: 10.1038/s41586-021-04312-6.


References
1.
Hei T, Ballas L, Brenner D, Geard C . Advances in radiobiological studies using a microbeam. J Radiat Res. 2009; 50 Suppl A:A7-A12. PMC: 3889709. DOI: 10.1269/jrr.08135s. View

2.
Leder K, Foo J, Skaggs B, Gorre M, Sawyers C, Michor F . Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia. PLoS One. 2011; 6(11):e27682. PMC: 3225363. DOI: 10.1371/journal.pone.0027682. View

3.
Roeder I, dInverno M . New experimental and theoretical investigations of hematopoietic stem cells and chronic myeloid leukemia. Blood Cells Mol Dis. 2009; 43(1):88-97. PMC: 3741041. DOI: 10.1016/j.bcmd.2009.03.003. View

4.
Kozubek S, Lukasova E, Mareckova A, Skalnikova M, Kozubek M, Bartova E . The topological organization of chromosomes 9 and 22 in cell nuclei has a determinative role in the induction of t(9,22) translocations and in the pathogenesis of t(9,22) leukemias. Chromosoma. 2000; 108(7):426-35. DOI: 10.1007/s004120050394. View

5.
Kellerer A, Rossi H . A generalized formulation of dual radiation action. Radiat Res. 2012; 178(2):AV204-13. DOI: 10.1667/rrav17.1. View